In The Channel
In The Channel
Podcasts
In The Channel
Podcasts
In The Channel

Is technology expense management the MSP practice you haven’t considered?

Technology expense management doesn’t show up on most MSPs’ radar – but according to Jason Wieser, SVP of channel sales at Calero, it probably should. In this episode, Wieser makes the case for TEM as a genuine recurring revenue practice, and explains why SaaS sprawl has become the front door into the conversation.

In The Channel

Red Hat’s Kennedy on why the swim lanes are gone – and what the partner program looks like now

Podcasts

The Buzz: ePlus buys Daymark, Cohesity expands Aspire partner program, and Exclaimer builds an MSP lane

ePlus acquires Daymark Solutions for its Microsoft cloud push, Cohesity adds specializations and rebates to its Aspire partner program, and Exclaimer debuts MSP Connect with PSA integrations. Plus, IBM deploys thousands of AI agents and CrowdStrike warns on frontier AI threats. Here’s your Wednesday, August 26 channel briefing.

In The Channel

Cisco brings sovereign infrastructure to Canada with air-gapped portfolio

Cisco has launched its Sovereign Critical Infrastructure portfolio in Canada, giving government, financial institutions, and healthcare providers a new option for air-gapped, on-premises deployment. Cisco Canada president Raj Juneja says the offering is open to the full partner ecosystem, with certifications consistent with existing portfolio requirements.

Podcasts

The Buzz: Cisco Canada launches sovereign critical infrastructure, ScanSource buys MicroAge for $220.5 million, and ESET Canada names cybersecurity scholarship winners

Cisco Canada launches its Sovereign Critical Infrastructure portfolio with Bell as lead partner, ScanSource acquires MicroAge for $220.5 million to augment partner services, and ESET Canada names three Women in Cybersecurity Scholarship winners. Plus CrowdStrike expands Project QuiltWorks to SMBs, Palo Alto Networks and NTT Data sign a $1 billion pact, and Auvik promotes Daniel Ochoa to CRO.